Hyperspectral imaging assists early diagnosis of Alzheimer s disease
26 May 2021
Imec clinical study identifies signs of plaque accumulation in the retina.
Symptoms spotted: retinal imaging
Diagnosis of Alzheimer s disease (AD) as early as possible in the progress of the condition continues to present a major global health challenge.
One potential bioimaging approach has been to look at the cells of a patient s retina, where evidence of amyloid plaque build-up was first indicated to be a possible biomarker for AD in 2015.
Subsequent research included the landmark US study undertaken in 2017, employing fluorescence imaging of the retina specifically as an alternative to other more complicated approaches to AD diagnosis.